Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5091

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pd (68071 5091 3)

Packaging label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets. Key details include NDC 68071-5091-3, elliptical white tablets debossed with '40' on one side and 'ATS' on the other. The label also notes storage temperature instructions and manufacturer Alkem Laboratories Limited, Mumbai, India.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph depicting cumulative incidence (%) on the y-axis over time in years on the x-axis, comparing Atorvastatin and Placebo groups. The graph shows two lines, with Atorvastatin having a consistently lower incidence than Placebo. Data includes a hazard ratio (HR=0.64) and a p-value (p=0.0005).*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A Kaplan-Meier curve chart comparing cumulative hazard percentages over time for Atorvastatin versus placebo. The x-axis shows time in years up to 5 years, while the y-axis shows cumulative hazard percentage up to 15%. The Atorvastatin group has a consistently lower cumulative hazard than the placebo group, with hazard ratio (HR) 0.63 and p-value 0.001 indicated.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph displaying the percentage of subjects experiencing a major cardiovascular event over a 5-year period. Two dosage groups of Atorvastatin are shown: 10 mg (dashed line) and 80 mg (solid line). The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes a hazard ratio (HR 0.78 [0.69-0.89]) with a p-value of 0.0002, indicating comparison data between dosages.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure diagram of Atorvastatin Calcium, showing its molecular framework including phenyl rings, fluorine substitution, and calcium ion coordination.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.